When.com Web Search

  1. Ads

    related to: her2 positive survival stories

Search results

  1. Results From The WOW.Com Content Network
  2. HER2 - Wikipedia

    en.wikipedia.org/wiki/HER2

    HER2 is the target of the monoclonal antibody trastuzumab (marketed as Herceptin). Trastuzumab is effective only in cancers where HER2 is over-expressed. One year of trastuzumab therapy is recommended for all patients with HER2-positive breast cancer who are also receiving chemotherapy. [33] Twelve months of trastuzumab therapy is optimal.

  3. List of breast cancer patients by survival status - Wikipedia

    en.wikipedia.org/wiki/List_of_breast_cancer...

    Former First Lady of the United States, Nancy Reagan (1921–2016) was a long-term breast cancer survivor.. This list of notable breast cancer patients includes people who made significant contributions to their respective fields and who were diagnosed with breast cancer at some point in their lives, as confirmed by public information.

  4. Trastuzumab - Wikipedia

    en.wikipedia.org/wiki/Trastuzumab

    In early-stage HER2-positive breast cancer, trastuzumab-containing regimens improved overall survival (Hazard ratio (HR) = 0.66) and disease-free survival (HR = 0.60). [39] Increased risk of heart failure (RR = 5.11) and decline in left ventricular ejection fraction ( relative risk RR = 1.83) were seen in these trials as well. [ 39 ]

  5. Breast cancer - Wikipedia

    en.wikipedia.org/wiki/Breast_cancer

    This is an accepted version of this page This is the latest accepted revision, reviewed on 14 January 2025. Cancer that originates in mammary glands Medical condition Breast cancer An illustration of breast cancer Specialty Surgical Oncology Symptoms A lump in a breast, a change in breast shape, dimpling of the skin, fluid from the nipple, a newly inverted nipple, a red scaly patch of skin on ...

  6. Police officers killed in Syracuse shooting identified

    www.aol.com/police-officers-killed-syracuse...

    Syracuse Police Chief Joseph Cecile, at the podium, speaks at a news conference on Monday, April 15, 2024, regarding the shooting deaths of two Syracuse-area officers in a shootout late Sunday.

  7. Abemaciclib - Wikipedia

    en.wikipedia.org/wiki/Abemaciclib

    Abemaciclib was approved for the adjuvant treatment of HR+, HER2-, node-positive adjuvant breast cancer at high risk of recurrence in March 2023. [15] [16] As of 2023, abemaciclib was involved in two Phase III clinical trials: The SARC041 study compares abemaciclib versus placebo in patients with advanced dedifferentiated liposarcoma. [17]

  1. Ads

    related to: her2 positive survival stories